wallstreet

Most Votes

(3 votes) Bristol Myers Squibb Offers $60 a Share For ImClone

ImClone, the maker of cancer drug Erbitux, has been offered $60 a share from Bristol Myers Squibb. Read more...

(2 votes) ImClone Shares Take Off 40% After Bristol Offer

ImClone, the biotech company that produces the cancer drug Erbitux, shares take off by 40% after Bristol Myers Squibb offered $60 a share to gain greater control of the cancer drug. Read more...

Syndicate content

Join Xomba Today

Do you like to write? Would you like to make a little extra money on the side? These people do. Join the Xomba community today.
Become a Member